i) The drug-protein interaction network
ii) The table result of interaction with LMBRD2_Q68DH5
| Protein | Type | Gene Name | Drug | Drug Source | R | FDR | Cancer | |
|---|---|---|---|---|---|---|---|---|
 |
LMBRD2_Q68DH5 | Canonical | LMBRD2 | 5-fluorouracil | GDSC1:179 | -0.15 | 2.768e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | AR-42 | GDSC1:272 | 0.138 | 4.541e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | AS601245 | GDSC1:207 | -0.147 | 3.092e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | BI-97C1 | GDSC2:1849 | 0.21 | 1.304e-03 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | BMS-345541 | GDSC2:1249 | -0.138 | 4.444e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | BMS-754807 | GDSC1:184 | -0.42 | 2.206e-02 | LUNG |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | cabozantinib | GDSC1:249 | -0.165 | 1.374e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | camptothecin | GDSC1:1494 | 0.238 | 2.100e-04 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | CD532 | GDSC1:449 | 0.156 | 2.117e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | CHIR-99021 | GDSC1:1241 | -0.158 | 1.915e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | cisplatin | GDSC1:1005 | -0.138 | 4.472e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | CP-724714 | GDSC1:255 | -0.148 | 2.971e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | cytarabine | GDSC1:1006 | 0.26 | 4.204e-05 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | foretinib | GDSC2:2040 | 0.142 | 3.825e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | GDC-0941 | GDSC1:1058 | 0.16 | 1.733e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | GDC0980 | GDSC1:382 | 0.149 | 2.879e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | GSK 269962A | GDSC1:1192 | 0.159 | 1.821e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | GTPL8020 | GDSC2:1855 | -0.205 | 1.669e-03 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | JNJ38877605 | GDSC1:284 | -0.145 | 3.394e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | lestaurtinib | GDSC1:1024 | 0.172 | 1.009e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | methotrexate | GDSC1:1008 | 0.193 | 3.369e-03 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | mitoxantrone | GDSC2:1810 | 0.194 | 3.169e-03 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | nilotinib | GDSC2:1013 | 0.161 | 1.681e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | nutlin-3 | GDSC1:1047 | -0.158 | 1.978e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | NVP-BEZ235 | GDSC1:1057 | 0.146 | 3.307e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | oxaliplatin | GDSC2:1089 | -0.157 | 2.056e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | PF-00299804 | GDSC1:363 | 0.16 | 1.781e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | quizartinib | GDSC1:254 | 0.143 | 3.714e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | TAK-715 | GDSC1:221 | -0.162 | 1.639e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | teniposide | GDSC2:1809 | 0.142 | 3.843e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | tubastatin-A | GDSC1:265 | -0.191 | 3.765e-03 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | UNC0638 | GDSC1:1236 | -0.137 | 4.763e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | WYE-125132 | GDSC1:317 | 0.165 | 1.396e-02 | ALL |
|
LMBRD2_Q68DH5 | Canonical | LMBRD2 | YM-155 | GDSC2:1941 | -0.186 | 4.825e-03 | ALL |
